Current Price Status
Stock is Under Pressure
Market is pricing a weaker earning growth potential than the industry average.
Undervalued stock can be true bargain buy if the stock is believed to be only under pressured for a short-term weak earning growth.
Company is in Positive Earning
- YSPSAH current price is 43.72% below OneDelta estimated fair value.
The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.
Relative Price Performance
OutperformedYSPSAH past 5-day return perform better than Pharmaceuticals industry average return by 1.19%
Above 30-Day AverageCurrent price RM2.15 is above than 30-day average RM2.15 by 0%
Bank Analyst Price Targets
Revenue & Earning Growth Analysis
Recent Positive Revenue Growth
YSPSAH managed to achieve better revenue growth for past 2 quarters by average +6%.
Potential Better Profit Growth
YSPSAH posted a better profit growth than average in the recent quarter.
Past Quarter Reports
|Quarter Date||Revenue (RM)||(%)||EPS (RM)||(%)|
Volume Trend Analysis
Recent Volume is Decreasing
Decreasing trading volume tends to keep stock price range bound in near term.
Low Volume/Liquidity Stock
Only RM20k worth of stock was traded for this stock past month. Low liquidity stock is danger for price manipulation and more difficult to sell at market price.
YSPSAH recent daily traded volume is NAN% lower than past month average.
|Past 30-Day||Past 5-Day|
|0k daily||0k daily|
Price History Chart
Past 30-day Average Price: RM2.15
Stock Fundamental Factors
Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.
Stock Company Profile
Y.S.P.SOUTHEAST ASIA HOLDING
Y.S.P. Southeast Asia Holding Bhd. engages in the business of importing, exporting, and manufacturing of pharmaceutical products. It operates through the following segments: Trading, Manufacturing, and Investment Holding. The Trading segment imports, exports, and trades various kinds of pharmaceutical, traditional herbal, and veterinary products. The company was founded in 1987 and is headquartered in Kuala Lumpur, Malaysia.